ArticleEMBO molecular medicine2017
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure.
Michael P Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled itcites it